Alaunos Therapeutics | ZIOP - Debt


Alaunos Therapeutics reported $10.99M in Debt for its fiscal quarter ending in March of 2023.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Amgen USD 54.6B 17M Dec/2025
AstraZeneca USD 33.92B 4.3B Mar/2026
Baxter International USD 9.78B 68M Dec/2025
Biogen USD 6.56B 275.1M Mar/2026
Bioline Rx USD 9.07M 2.31M Mar/2026
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Celltrion KRW 160.58B 733.3M Mar/2026
Corcept Therapeutics USD 6.11M 251K Dec/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Curis USD 0 0 Jun/2022
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Divis Laboratories Ltd INR 40M 40M Mar/2025
Gilead Sciences USD 24.94B 5M Dec/2025
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Incyte USD 39.43M 982K Mar/2026
Intrexon USD 0 13.82M Jun/2024
Ionis Pharmaceuticals USD 2.34B 9.5M Mar/2026
J&J USD 54.99B 7.05B Mar/2026
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Merck USD 49.34B 7.97B Dec/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Novartis USD 47B 11.62B Mar/2026
Organigram Holdings CAD 8.2M 554K Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 63.73B 231M Mar/2026
Pharma Mar EUR 47.54M 1.88M Mar/2026
PTC Therapeutics USD 286.94M 2.42B Mar/2026
Qiagen NV USD 1.81B 314.82M Dec/2025
Regeneron Pharmaceuticals USD 2.71B 300K Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sartorius EUR 4.28B 372.9M Dec/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
TG Therapeutics USD 253.71M 8.37M Dec/2025
Tilray USD 640.95M 35.17M Jun/2022
Verastem USD 66.79M 26.7M Sep/2024
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026